The following IP guidance note provides comprehensive and up to date legal information covering:
DRAFTING FOR BREXIT: For the latest information on the impact of Brexit on the drafting, negotiation and enforceability of this Precedent, see Practice Notes: Brexit—drafting boilerplate clauses and Brexit—drafting commercial clauses.
[insert address of sender]
Our ref: [insert reference]
Your ref: [insert reference]
[insert address of discloser]
Date: [insert date]
Dear [insert organisation name],
[insert purpose or project](the Purpose)
We refer to the Purpose. You shall disclose Confidential Information to us[ for it to be used for the Purpose] in accordance with the terms set out in this letter (the Agreement).
For the purposes of this Agreement:
[Authorised Person means any of our officers, directors, members, partners, employees, consultants, agents, representatives, subcontractors or professional advisers, and any other person whom you have previously designated in writing as authorised];
Confidential Information means the information listed in the Appendix to this Agreement excluding any information which:
is, or was already known or available to us, other than pursuant to or through breach of any confidentiality obligation owed to you;
is, or will be, in the public domain other than through any breach of this Agreement (save that any publicly available information shall
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234